Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-21

Clinical Trial Update: Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study evaluating gabapentin and ketamine to prevent or treat acute and chronic pain in locally advanced head and neck canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Ketamine (ketamine)

Snippet

Sponsor: Natalie Lockney | Conditions: Head and Neck Cancer, Locally Advanced Head and Neck Carcinoma | Phase 1, Phase 2 | Status: RECRUITING